← Back to Search

Selective Nerve Root Block for Lumbar Radiculopathy

Phase 4
Waitlist Available
Led By Michael Steinmetz, MD
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

Study Summary

Threshold Response of Lumbar Selective Nerve Root Block in Predicting Good Outcome Following Lumbar Foraminotomy

Eligible Conditions
  • Lumbar Radiculopathy
  • Degenerative Spinal Stenosis
  • Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Analog Scale (VAS) Leg Pain Score
Secondary outcome measures
EQ-5D Questionnaire
Oswestry Disability Index Questionnaire (ODI)
Pain Disability Questionnaire (PDQ)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Selective Nerve Root BlockExperimental Treatment1 Intervention
Patient will receive a Selective Nerve Root Block injection at the target level prior to surgical intervention.

Find a Location

Who is running the clinical trial?

Lumbar Spine Research SocietyUNKNOWN
The Cleveland ClinicLead Sponsor
1,026 Previous Clinical Trials
1,366,065 Total Patients Enrolled
Michael Steinmetz, MDPrincipal Investigator - The Cleveland Clinic
Cleveland Clinic Hospital
Texas Tech University Hlth Sci Ctr School Of Medicine (Medical School)
Cleveland Clinic Fndn (Residency)
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025